You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先瑞達醫療(6669.HK)今日起招股 引入匯添富等多家基石
格隆匯 08-12 13:11
格隆匯8月12日丨先瑞達醫療-B(6669.HK)公佈招股詳情,計劃發行6,863.3萬股股份,其中90%為國際發售,10%為公開發售,另有最多15%超額配股權。招股價介乎22.2-23.8港元,每手1000股。由今日(12日)至下週二(17日)公開招股,預計將於8月24日上市。摩根士丹利及中金為聯席保薦人。先瑞達醫療是一家領先的中國創新醫療器械企業,專注於提供血管疾病的“介入無植入”治療方案。截至最後實際可行日期,公司已有四款產品實現商業化,產品管線涵蓋24款處於不同開發階段的在研產品。此外據悉,多名基石投資者同意按發售價認購可供認購的發售股份數目,總額約1.05億美元,包括匯添富、CPE Investment Wu、中金公司、達觀國際、Panjing Fund、Dymon Asia、保銀、易方達基金及新里程集團等。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account